Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients
- PMID: 2223142
- DOI: 10.3109/02841869009092990
Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients
Abstract
Axillary nodal status was analysed in 960 consecutive cases of primary invasive breast cancer operated in two Danish hospitals. After stratification according to the number of nodes removed, the rate of node positivity in each subgroup was calculated. We found that the probability of finding at least one metastatic node increased continuously up to about 10 removed nodes. In lymph node negative patients, who did not receive any adjuvant treatment, there was a significant association between the recurrence-free survival and the number of nodes removed, provided that less than 8-10 nodes had been collected. The percentage of node positivity in each subgroup seemed to level off above 10 nodes at about 64%, suggesting that this represents the true rate of node positivity at the time of primary surgery. We conclude that about 10 axillary nodes should be removed in order to minimize the risk of erroneous classification of the axilla.
Similar articles
-
The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1328-34. doi: 10.1016/j.ijrobp.2006.07.015. Epub 2006 Sep 25. Int J Radiat Oncol Biol Phys. 2006. PMID: 16997505
-
Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.J Am Coll Surg. 1996 Dec;183(6):575-82. J Am Coll Surg. 1996. PMID: 8957459
-
[Management of the axilla in breast cancer: evidences and unresolved issues].Orv Hetil. 2001 Sep 9;142(36):1941-50. Orv Hetil. 2001. PMID: 11680099 Review. Hungarian.
-
[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765. Orv Hetil. 2013. PMID: 24292111 Clinical Trial. Hungarian.
-
Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022. J Surg Oncol. 2004. PMID: 14991881 Review.
Cited by
-
Micrometastases in axillary lymph nodes in breast cancer, post-neoadjuvant systemic therapy.Breast Cancer Res. 2024 Jul 31;26(1):120. doi: 10.1186/s13058-024-01874-x. Breast Cancer Res. 2024. PMID: 39085833 Free PMC article.
-
Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.Ann Surg. 1997 Sep;226(3):271-6; discussion 276-8. doi: 10.1097/00000658-199709000-00006. Ann Surg. 1997. PMID: 9339933 Free PMC article. Clinical Trial.
-
Estimating the overlap between sentinel lymph nodes and axillary node samples in breast cancer.Pathol Oncol Res. 1999;5(2):129-33. doi: 10.1053/paor.1999.0174. Pathol Oncol Res. 1999. PMID: 10393365
-
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?World J Urol. 2012 Dec;30(6):807-14. doi: 10.1007/s00345-012-0910-5. Epub 2012 Jul 26. World J Urol. 2012. PMID: 22832587
-
Axillary staging of breast cancer and the sentinel node.J Clin Pathol. 2000 Oct;53(10):733-41. doi: 10.1136/jcp.53.10.733. J Clin Pathol. 2000. PMID: 11064665 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical